Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck

被引：0
|
作者：
Keil, F. [1 ]
Selzer, E. [2 ]
Berghold, A. [3 ]
Reinisch, S. [4 ]
de Vries, A. [5 ]
Greil, R. [6 ]
Bachtiary, B. [7 ]
Tinchon, C. [8 ]
Anderhuber, W. [9 ]
Burian, M. [10 ]
Kasparek, A. K. [11 ]
Elsaesser, W. [12 ]
Kainz, H. [8 ]
Riedl, R. [3 ]
Kapp, K. [13 ]
Kopp, M. [14 ]
Kornek, G. [15 ,16 ]
机构：
[1] Hanuschkrankenhaus, Med Abt 3, Vienna, Austria
[2] Med Univ Vienna, Univ Clin Radiat Therapy & Radiat Biol, Vienna, Austria
[3] Inst Med Informat Stat & Documentat, Graz, Austria
[4] Med Univ Graz, Clin Dept Gen Head & Neck, Graz, Austria
[5] Landeskrankenhaus Feldkirch Radiat Therapy, Feldkirch, Austria
[6] Paracelsus Med Univ, Univ Clin Internal Med Salzburg 3, Salzburg, Austria
[7] Med Univ Vienna, Univ Clin Radiat Therapy & Radiat Biol, Vienna, Austria
[8] Landeskrankenhaus Leoben, Dept Internal Med Hemato & Oncol, Leoben, Austria
[9] Landeskrankenhaus Leoben, Dept Head & Neck, Leoben, Austria
[10] Hosp Barmherzige Schwestern Linz, Dept Head & Neck, Linz, Austria
[11] Univ Clin Internal Med Graz, Dept Clin Oncol, Graz, Austria
[12] Landeskrankenhaus Feldkirch, Dept Head & Neck, Feldkirch, Austria
[13] Univ Clin Radiat Therapy Radiooncol Graz, Graz, Austria
[14] Paracelsus Med Univ, Univ Clin Salzburg, Salzburg, Austria
[15] Med Univ Vienna, Gen Hosp Vienna, Dept Internal Med 1, Vienna, Austria
[16] Med Univ Vienna, Gen Hosp Vienna, Ctr Canc, Vienna, Austria
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P826
引用
下载
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [31] Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Hideaki Katori
    Mamoru Tsukuda
    Kiichi Watai
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 399 - 406
  • [32] Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Katori, Hideaki
    Tsukuda, Mamoru
    Watai, Kiichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (03) : 399 - 406
  • [33] Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck. Results from a phase II study with docetaxel, cisplatin and 5-fluorouracil
    Katsilieris, L
    Stavrinidis, E
    Trichas, M
    Amous, A
    Lagogiannis, G
    Faratzis, G
    Roupakia, A
    Liossi, P
    Stavrianos, S
    Rapidis, AD
    ORAL ONCOLOGY, 2005, 1 (01) : 127 - 127
  • [34] CISPLATIN AND 5-FLUOROURACIL CHEMOTHERAPY IN ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    MERCIER, RJ
    NEAL, GD
    MATTOX, DE
    GATES, GA
    POMEROY, TC
    VONHOFF, DD
    CANCER, 1987, 60 (11) : 2609 - 2612
  • [35] Induction Chemotherapy with Docetaxel, Cisplatin and Capecitabine, Followed by Combined Cetuximab and Radiotherapy in Patients with Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck: A Phase I-II Study
    Perri, Francesco
    Muto, Paolo
    Argenone, Angela
    Ionna, Franco
    Longo, Francesco
    Fulciniti, Franco
    Sandomenico, Fabio
    Daponte, Antonio
    Caponigro, Francesco
    ONCOLOGY, 2013, 84 (04) : 251 - 254
  • [36] A randomized of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by surgery versus surgery upfront in locally advanced and resectable oral squamous cell carcinoma
    Zhong, Lai-ping
    Zhang, Zhi-yuan
    Zhang, Chen-ping
    Ren, Guo-xin
    Guo, Wei
    Sun, Jian
    Zhu, Han-guang
    Tu, Wen-yong
    Wang, Zhong-he
    Hu, Yong-jie
    Ji, Tong
    Yang, Wen-jun
    Ye, Wei-min
    Li, Jun
    He, Yue
    Wang, Yan-an
    Xu, Li-qun
    ORAL ONCOLOGY, 2013, 49 : S20 - S21
  • [37] Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck
    Schultz, J. D.
    Bran, G.
    Anders, C.
    Sadick, H.
    Faber, A.
    Hoermann, K.
    Sauter, A.
    ONCOLOGY REPORTS, 2010, 24 (05) : 1213 - 1216
  • [38] COST UTILITY OF DOCETAXEL AS INDUCTION CHEMOTHERAPY FOLLOWED BY CHEMORADIATION IN LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
    Parthan, Anju
    Posner, Marshall R.
    Brammer, Caroline
    Beltran, Philippe
    Jansen, Jeroen P.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2009, 31 (10): : 1255 - 1262
  • [39] A prospective comparative study on biweekly docetaxel, cisplatin, 5-fluorouracil, leucovorin (TPFL) versus triweekly TPF as an induction chemotherapy in locally advanced squamous cell carcinoma of head and neck
    Anantharamu, S.
    Jacob, L. A.
    Dasappa, L.
    Babu, M. C. Suresh
    Lokesh, K. N.
    Rudresha, A. H.
    Krishnappa, R. Lakkavalli
    Saldanha, S. C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S850 - S850
  • [40] Efficacy of brachytherapy concomitant with chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in unresectable head and neck squamous cell carcinoma
    Wang, Xing
    Meng, Jian
    JOURNAL OF BUON, 2016, 21 (03): : 588 - 593
12345